Barely Significant
← all excerpts

What Can We Learn From Clinical Trials of Exon Skipping for DMD?

Mol Ther Nucleic Acids · 2014 · PMC4027981 · PMID 24618851

1
hedged sentence
closest p
boldest claim

The sentences

a clear trendno p-value reported
16 Overall, the Eteplirsen trials showed a clear trend of dose-dependent increase in dystrophin expression.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.